Global Longlife Hospital and Research Limited (BSE: 543520)
Health Care · Health Care Providers & Services · IN
Rs12.52
+3.05% today · -49.9% 1Y
Global Longlife Hospital and Research Limited (BSE: 543520) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.36M.
Over the last twelve months the share price has lost 49.9%, trading between 9.00 and 25.80.
Tweenvest scores Global Longlife Hospital and Research Limited across four factors: quality 63/100, value 66/100. Its strongest factor is value.
543520 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.36M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.64
- Dividend yield
- —
- Beta (5Y)
- -0.20
- 52-week high
- Rs25.80
- 52-week low
- Rs9.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.50M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mono Pharmacare LimitedNSEI: MONOPHARMA | $1.62M | Rs8.90 | +4.09% |
| Acro Biomedical Co., Ltd.OTCPK: ACBM | $1.56M | $— | — |
| Virax Biolabs Group LimitedNasdaqCM: VRAX | $1.49M | $1.87 | 0.00% |
| Medical Marijuana, Inc.OTCPK: MJNA | $1.39M | $0.00 | -50.00% |
| Universal Ibogaine Inc.TSXV: IBO | $1.14M | CA$— | — |
| Arzneiwerk AG VIDADB: TLIK | $1.13M | €0.16 | +33.88% |
| Family Care Hospitals LimitedBSE: 516110 | $1.11M | Rs1.98 | +12.50% |
| Dipna Pharmachem LimitedBSE: 543594 | $1.07M | Rs3.95 | -4.82% |
Figures last refreshed Oct 11, 2026.